Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|October 5, 2002
Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and ConnecticutGrace Lu-Yao, Peter C Albertsen, Janet L Stanford, et al.
Cancers|March 10, 2022
Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based StudyNikita Nikita, Joshua Banks, Scott W Keith, et al.
Cancers|December 24, 2021
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping ReviewAmy L Shaver, Swapnil Sharma, Nikita Nikita, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN ExperienceLaurie K Pearson, Yue Zheng, Nikita Nikita, et al.
Cancers|August 12, 2022
Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping ReviewYash B Shah, Amy L Shaver, Jacob Beiriger, et al.
BMJ Open|July 21, 2022
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocolAmy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
Journal of Geriatric Oncology|March 23, 2020
Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapyGrace Lu-Yao, Ginah Nightingale, Nikita Nikita, et al.
Journal of the National Cancer Institute|September 23, 2024
Disparities in the utilization of magnetic resonance imaging for prostate cancer detection: a population-based studyChristiane J El Khoury, Stephen J Freedland, Krupa Gandhi, et al.
Clinical Genitourinary Cancer|March 8, 2024
Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial CarcinomaSarah Fleming, Dina Gifkins, Helaine E Resnick, et al.
BMC Cancer|June 3, 2021
Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patientsWeelic Chong, Zhenchao Zhang, Rui Luo, et al.
Pageof 5